Helping women to keep their blood pressure at normal levels could reduce their risk of experiencing pregnancy complications, ...

Viking Therapeutics VKTX announced that it has completed enrolling patients in its exploratory maintenance dosing study of VK2735, the company's dual agonist of the GLP-1 and GIP receptors. VKTX is ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

The same BMI criteria were used to determine eligibility for study randomization. Any individual who completed the run-in phase but did not fulfill the BMI randomization criteria was considered ...